Literature DB >> 23849959

Pressure-temperature folding landscape in proteins involved in neurodegenerative diseases and cancer.

Yraima Cordeiro1, Debora Foguel, Jerson L Silva.   

Abstract

High hydrostatic pressure (HHP) is a valuable tool to study processes such as protein folding, protein hydration and protein-protein interactions. HHP is a nondestructive technique because it reversibly affects internal cavities excluded from the solvent present in the hydrophobic core of proteins. HHP allows the solvation of buried amino acid side chains, thus shifting the equilibrium towards states of the studied molecule or molecular ensemble that occupy smaller volumes. HHP has long been used to dissociate multimeric proteins and protein aggregates and allows investigation of intermediate folding states, some of which are formed by proteins involved in human degenerative diseases, such as spongiform encephalopathies and Parkinson's disease, as well as cancer. When coupled with nuclear magnetic resonance and spectroscopic methods such as infrared and fluorescence spectroscopy, HHP treatment facilitates the understanding of protein folding and misfolding processes; the latter is related to protein aggregation into amyloid or amorphous species. In this review, we will address how HHP provides information about intermediate folding states and the aggregation processes of p53, which is related to cancer, and prion proteins, transthyretin and α-synuclein, which are related to human degenerative diseases.
Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  1-anilino 8-naphthalene sulfonate; 4, 4′-bis(1-anilinonaphthalene 8-sulfonate); ANS; Amyloid; DA; Degenerative disease; FTIR; Fourier transform infrared; HHP; High pressure; I state; LB; Lewy bodies; NMR; PD; Parkinson's disease; PrP; Protein aggregation; Protein misfolding; TEM; TTR; alpha-synuclein; bis-ANS; dopamine; high hydrostatic pressure; intermediate state; nuclear magnetic resonance; p53; p53 tumor suppressor protein; prion protein; rPrP; recombinant prion protein; transmission electron microscopy; transthyretin; α-syn

Mesh:

Substances:

Year:  2013        PMID: 23849959     DOI: 10.1016/j.bpc.2013.06.002

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  6 in total

1.  High pressure promotes alpha-synuclein aggregation in cultured neuronal cells.

Authors:  Urszula Golebiewska; Suzanne Scarlata
Journal:  FEBS Lett       Date:  2015-10-03       Impact factor: 4.124

Review 2.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

3.  α-Helical protein absorption at post-traumatic epileptic foci monitored by Fourier transform infrared mapping.

Authors:  Siyang Xiang; Dong Zhao; Hongxia Hao; X U Wang; Ling Li; Tiantong Yang
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

4.  Unique properties of human β-defensin 6 (hBD6) and glycosaminoglycan complex: sandwich-like dimerization and competition with the chemokine receptor 2 (CCR2) binding site.

Authors:  Viviane S De Paula; Vitor H Pomin; Ana Paula Valente
Journal:  J Biol Chem       Date:  2014-06-26       Impact factor: 5.157

Review 5.  "What Doesn't Kill You Makes You Stronger": Future Applications of Amyloid Aggregates in Biomedicine.

Authors:  Sherin Abdelrahman; Mawadda Alghrably; Joanna Izabela Lachowicz; Abdul-Hamid Emwas; Charlotte A E Hauser; Mariusz Jaremko
Journal:  Molecules       Date:  2020-11-11       Impact factor: 4.411

6.  Status of the Parkinson's disease gene family expression in non-small-cell lung cancer.

Authors:  Quan Xing Liu; Hong Zheng; Xu Feng Deng; Dong Zhou; Ji Gang Dai
Journal:  World J Surg Oncol       Date:  2015-08-07       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.